Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11812
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWoods, Katherineen
dc.contributor.authorCebon, Jonathan Sen
dc.date.accessioned2015-05-16T01:26:26Z
dc.date.available2015-05-16T01:26:26Z
dc.date.issued2013-07-17en
dc.identifier.citationClinical Cancer Research 2013; 19(15): 4021-3en
dc.identifier.govdoc23864163en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11812en
dc.description.abstractDespite success with immune checkpoint inhibitors, clinical benefit from cancer vaccines remains elusive. Combined targeting of melanoma-specific CD4(+) and CD8(+) T-lymphocyte epitopes was associated with improved survival compared with targeting either alone, or when a nonspecific helper epitope was used. We discuss the potential role of antigen-specific CD4 help.en
dc.language.isoenen
dc.subject.otherAntigens, CD4.immunologyen
dc.subject.otherCD4-Positive T-Lymphocytesen
dc.subject.otherCD8-Positive T-Lymphocytesen
dc.subject.otherCancer Vaccines.immunology.therapeutic useen
dc.subject.otherEpitopes, T-Lymphocyte.immunologyen
dc.subject.otherFlow Cytometryen
dc.subject.otherHumansen
dc.subject.otherImmunotherapyen
dc.subject.otherLymphocyte Activation.immunologyen
dc.subject.otherMelanoma.immunology.pathology.therapyen
dc.subject.otherSurvival Analysisen
dc.titleTumor-specific T-cell help is associated with improved survival in melanoma.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical Cancer Researchen
dc.identifier.affiliationLudwig Institute for Cancer Research Melbourne-Austin Branch, Heidelberg, Australiaen
dc.identifier.doi10.1158/1078-0432.CCR-13-1349en
dc.description.pages4021-3en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/23864163en
dc.type.austinJournal Articleen
local.name.researcherCebon, Jonathan S
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Jan 9, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.